Cientistas identificam circuito cerebral responsável pela transição para a dor crônica

Pesquisadores da Universidade do Colorado em Boulder localizaram uma região do cérebro chamada córtex insular granular caudal, ou CGIC, que atua como um interruptor que transforma dor aguda em dor crônica. Em estudos com animais, desativar esse circuito impediu o desenvolvimento da dor crônica ou a reverteu após sua instalação. As descobertas, publicadas no Journal of Neuroscience, abrem caminho para novos tratamentos além dos opioides.

Uma equipe liderada por Linda Watkins, professora distinta de neurociência comportamental na Universidade do Colorado em Boulder, estudou o CGIC em ratos com lesões no nervo ciático. Eles utilizaram métodos quimiogenéticos avançados e proteínas fluorescentes para rastrear e silenciar neurônios específicos. Desativar a via do CGIC impediu que os sinais de dor persistissem após a cicatrização da lesão, eliminando sintomas como a alodinia, condição na qual um toque leve torna-se doloroso. Watkins afirmou: 'Se esse decisor crucial for silenciado, a dor crônica não ocorre. Se ela já estiver presente, a dor crônica desaparece'.

Artigos relacionados

Illustration of distant astrocytes signaling via CCN1 protein to enhance microglia debris clearance in mouse spinal cord injury.
Imagem gerada por IA

Cedars-Sinai study maps how distant astrocytes help microglia clear debris after spinal cord injury

Reportado por IA Imagem gerada por IA Verificado

Scientists at Cedars-Sinai Medical Center report that a subset of astrocytes located away from a spinal cord injury can help drive repair in mice by releasing the protein CCN1, which alters microglia metabolism to improve cleanup of lipid-rich nerve debris. The work, published in Nature, also found evidence of a similar CCN1-linked response in human spinal cord tissue from people with multiple sclerosis.

Researchers at the University of Technology Sydney report that inducing localized inflammation in a striatal region involved in action selection pushed rats toward more goal-directed, outcome-sensitive behavior rather than automatic habits. The team traced the effect to disrupted astrocyte function, a finding they say could inform future approaches to compulsive disorders such as OCD and addiction.

Reportado por IA

Researchers are revisiting substance P, a neuropeptide linked to migraine pain, after it was dismissed as a treatment target 25 years ago. A recent study shows it causes headaches and blood vessel dilation in both migraine sufferers and others, suggesting potential for new therapies. This comes amid advances in blocking other migraine-related peptides like CGRP and PACAP.

Researchers at Oregon Health & Science University have pinpointed specific sites on NMDA receptors targeted by harmful antibodies in a rare autoimmune brain disorder known as "Brain on Fire." This discovery, published in Science Advances, could lead to more precise treatments and earlier detection. The condition affects about 1 in 1 million people annually, mainly young adults, causing severe symptoms like seizures and memory loss.

Reportado por IA

Researchers have discovered that psychedelic substances suppress visual processing in the brain, leading to hallucinations by drawing on memory fragments. The study, conducted using advanced imaging on mice, shows how slow brain waves shift perception toward internal recall. These findings could inform therapies for depression and anxiety.

Este site usa cookies

Usamos cookies para análise para melhorar nosso site. Leia nossa política de privacidade para mais informações.
Recusar